Skip navigation

Zoetis Inc.

Pharmaceuticals
United States
2016 Revenue (US$ Millions)$4,888
Revenue Growth (%)2.58%
Net Income (US$ Millions)$821
Earnings Per Share (US$)$1.65
EPS Growth Rate (%)142.65%
Profit Margin16.80%
Total Equity (US$ Millions)$1,487
Return on Equity (%)76.87%
Long Term Debt (US$ Millions)$4,468
Debt To Equity Ratio (%)3.00%
Total Assets (US$ Millions)$7,649
Current Assets (US$ Millions)$3,390
Current Liabilities (US$ Millions)$1,117
Cost of Goods Sold (US$ Millions)$1,666
Inventory Turnover1.12